Skip to content

Evaluation of neurocognitive-physical function after treatment of pediatric solid cancer

Evaluation of neurocognitive-physical function after treatment of pediatric cancer

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0011000
Enrollment
96
Registered
2025-09-09
Start date
2023-01-18
Completion date
Unknown
Last updated
2025-09-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Seoul National University Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Radiotherapy Group: - Diagnosed with a primary brain tumor at the age of 3–18 years at the time of diagnosis - Undergoing radiotherapy for curative or adjuvant purposes for a brain tumor - Receiving treatment with a radiotherapy plan established through CT simulation to calculate radiation doses for specific brain regions - No history of prior radiotherapy - Capable of understanding and completing neurocognitive and physical function assessments - Sufficient physical activity level (Lansky score = 50) - Consent provided by the patient and their guardian for long-term follow-up and assessments Surgery-only Group: - Diagnosed with a primary brain tumor at the age of 3–18 years at the time of diagnosis - Underwent surgery for a brain tumor with curative intent - No prior history of radiotherapy and no planned radiotherapy at the time of study participation - Capable of understanding and completing neurocognitive and physical function assessments - Sufficient physical activity level (Lansky score = 50) - Consent provided by the patient and their guardian for long-term follow-up and assessments

Exclusion criteria

Exclusion criteria: - History of surgery or radiotherapy for other conditions involving the brain - Undergoing 2D radiotherapy or palliative radiotherapy - Uncontrolled seizures or altered consciousness posing a risk of falls or injury during assessments - Inability to undergo contrast-enhanced MRI for follow-up purposes - Tumor types unsuitable for long-term follow-up (e.g., inoperable brainstem glioma, high-grade glioma without curative resection, AT/RT)

Design outcomes

Primary

MeasureTime frame
Neurocognitive Function Assessments;Physical Function Assessments

Secondary

MeasureTime frame
Clinical Outcome (e.g., survival status, recurrence);Behavioral and Emotional Assessments;Family Environment Assessments;Saliva-based genetic analysis data (Radiotherapy Group only);CT, MRI, and radiotherapy planning data related to radiotherapy

Countries

Korea, Republic of

Contacts

Public ContactJoo Ho Lee

Seoul National University Hospital

jooholee@snu.ac.kr+82-2-2072-2819

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026